373 related articles for article (PubMed ID: 10201631)
1. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
[TBL] [Abstract][Full Text] [Related]
2. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
4. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system manifestations of marginal zone B-cell lymphoma.
Bayraktar S; Stefanovic A; Montague N; Davis J; Murray T; Lossos IS
Ann Hematol; 2010 Oct; 89(10):1003-9. PubMed ID: 20440502
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic lymphoma: epidemiology and pathogenesis.
Sjö LD
Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
[TBL] [Abstract][Full Text] [Related]
11. BCL10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic findings and frequency of clonality detected by the polymerase chain reaction in ocular adnexal lymphoproliferative lesions.
White VA; Gascoyne RD; McNeil BK; Chang WY; Brewer LV; Rootman J
Mod Pathol; 1996 Nov; 9(11):1052-61. PubMed ID: 8933515
[TBL] [Abstract][Full Text] [Related]
14. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy.
Ferreri AJ; Ponzoni M; Guidoboni M; De Conciliis C; Resti AG; Mazzi B; Lettini AA; Demeter J; Dell'Oro S; Doglioni C; Villa E; Boiocchi M; Dolcetti R
J Clin Oncol; 2005 Aug; 23(22):5067-73. PubMed ID: 15968003
[TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin lymphoma of the breast.
Ganjoo K; Advani R; Mariappan MR; McMillan A; Horning S
Cancer; 2007 Jul; 110(1):25-30. PubMed ID: 17541937
[TBL] [Abstract][Full Text] [Related]
18. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.
Mannami T; Yoshino T; Oshima K; Takase S; Kondo E; Ohara N; Nakagawa H; Ohtsuki H; Harada M; Akagi T
Mod Pathol; 2001 Jul; 14(7):641-9. PubMed ID: 11454995
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.
Chanudet E; Zhou Y; Bacon CM; Wotherspoon AC; Müller-Hermelink HK; Adam P; Dong HY; de Jong D; Li Y; Wei R; Gong X; Wu Q; Ranaldi R; Goteri G; Pileri SA; Ye H; Hamoudi RA; Liu H; Radford J; Du MQ
J Pathol; 2006 Jul; 209(3):344-51. PubMed ID: 16583361
[TBL] [Abstract][Full Text] [Related]
20. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
